Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Feb 23, 2023

BUY
$242.49 - $301.46 $18.8 Million - $23.3 Million
77,331 New
77,331 $19 Million
Q3 2022

Nov 17, 2022

BUY
$242.49 - $301.46 $18.7 Million - $23.3 Million
77,317 Added 552264.31%
77,331 $19.3 Million
Q2 2022

Aug 17, 2022

BUY
$224.73 - $338.64 $224 - $338
1 Added 7.69%
14 $3,000
Q1 2022

May 13, 2022

SELL
$277.25 - $366.29 $20.7 Million - $27.4 Million
-74,754 Reduced 99.98%
13 $4,000
Q4 2021

Feb 15, 2022

BUY
$300.63 - $371.35 $22.5 Million - $27.8 Million
74,754 Added 575030.75%
74,767 $26.9 Million
Q3 2021

Nov 18, 2021

SELL
$310.19 - $376.2 $1.79 Million - $2.17 Million
-5,757 Reduced 99.77%
13 $4,000
Q2 2021

Aug 17, 2021

BUY
$262.71 - $351.17 $180,744 - $241,604
688 Added 13.54%
5,770 $1.8 Million
Q1 2021

May 14, 2021

BUY
$285.92 - $355.13 $1.45 Million - $1.8 Million
5,082 New
5,082 $1.62 Million
Q4 2020

Feb 19, 2021

SELL
$251.88 - $324.2 $19.5 Million - $25.1 Million
-77,451 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$141.4 - $257.09 $11 Million - $19.9 Million
77,451 New
77,451 $18.7 Million
Q4 2019

Feb 21, 2020

SELL
$159.31 - $223.54 $8.74 Million - $12.3 Million
-54,881 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$175.89 - $279.23 $503,573 - $799,435
2,863 Added 5.5%
54,881 $9.76 Million
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $414,585 - $470,720
1,652 Added 3.28%
52,018 $13.6 Million
Q1 2019

May 15, 2019

BUY
$276.39 - $362.25 $556,649 - $729,571
2,014 Added 4.17%
50,366 $14.4 Million
Q4 2018

Feb 15, 2019

BUY
$281.08 - $444.25 $882,872 - $1.4 Million
3,141 Added 6.95%
48,352 $17.3 Million
Q3 2018

Nov 15, 2018

BUY
$354.53 - $449.75 $165,565 - $210,033
467 Added 1.04%
45,211 $20.3 Million
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $12.4 Million - $20 Million
44,744 New
44,744 $18.5 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.